SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Calamity Jane — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMartha Canary
Date of birth1856-05-01
IdentifiersMRN HR-NI008-SYN-TD; SSN (made up) 000-08-9532
Document date1901-03-30
AuthorRuth Ann Kessler, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-week review: naltrexone, liver stiffness, mood and benefits. [S]

History of Present Illness

Ms. Canary returns four weeks after intake. She has had no alcohol. Her tooth was removed at the dental clinic the day after her sick visit, and she finished the amoxicillin; the pain and swelling are gone. She has missed about eight of the last 21 naltrexone tablets: a bottle was lost when she moved her things, and some days she forgot. Cravings are milder on the days she takes it. She has had no nausea or stomach pain. She sleeps five to six hours and her mood is better. Her Medicaid and SNAP have been approved. She has called the peer recovery specialist twice and went to one women's meeting. [S]

ElementDetail
AlcoholNone for four weeks
NaltrexoneAbout eight of 21 doses missed; no side effects
Dental abscessTooth removed; healed
MoodPHQ-9 9; GAD-7 7
BenefitsMedicaid and SNAP approved

Review of Systems

SystemResultFinding
ConstitutionalNegativeEnergy better; weight rising
Ears, nose, mouth, and throatNegativeJaw pain and swelling gone
GastrointestinalNegativeNo nausea, abdominal pain or yellowing
PsychiatricPositiveSome low days; cravings milder; no thoughts of suicide or self-harm

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Gabapentin 300 mg oral capsule on a written five-day schedule for alcohol withdrawal: 300 mg in the morning, 300 mg in the afternoon and 600 mg at bedtime for three days, then 300 mg twice daily on day four, 300 mg at bedtime on day five, then stop; dispensed for the five days onlyPer the written five-day scheduleOral route1901-03-02 to 1901-03-06completedS
Thiamine 100 mg by intramuscular injection once daily for three days, given in the clinic100 mg intramuscularly once daily for three daysIntramuscular route1901-03-02 to 1901-03-04completedS
Thiamine 100 mg oral tablet, one tablet dailyOne tablet dailyOral route1901-03-05activeS
Folic acid 1 mg oral tablet, one tablet dailyOne tablet dailyOral route1901-03-02activeS
Potassium chloride extended-release 20 mEq oral tablet, one tablet daily with food for five daysOne tablet daily with food for five daysOral route1901-03-02 to 1901-03-06completedS
Magnesium oxide 400 mg oral tablet, one tablet twice daily for two weeksOne tablet twice daily for two weeksOral route1901-03-02 to 1901-03-16completedS
Naltrexone 50 mg oral tablet, one tablet dailyOne tablet dailyOral route1901-03-09 to 1901-03-30completedS
Extended-release naltrexone 380 mg by deep intramuscular injection into the buttock every four weeks, given by the clinic nurse380 mg intramuscularly every four weeksIntramuscular route1901-03-30activeS
Amoxicillin 500 mg oral capsule, one capsule three times daily for five daysOne capsule three times daily for five daysOral route1901-03-23 to 1901-03-28completedS
Ibuprofen 400 mg oral tablet, one tablet with food every 8 hours as needed for tooth pain, for up to five daysOne tablet with food every 8 hours as needed, up to five daysOral route1901-03-23 to 1901-03-28completedS
Acetaminophen 500 mg oral tablet, one tablet every 6 hours as needed with the ibuprofen, no more than 2,000 mg a day, for up to five daysOne tablet every 6 hours as needed, no more than 2,000 mg a dayOral route1901-03-23 to 1901-03-28completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1901-03-30Body height165cmS
1901-03-30Body weight50.9kgS
1901-03-30Body mass index (BMI) [Ratio]18.7kg/m2S
1901-03-30Systolic blood pressure122mm[Hg]S
1901-03-30Diastolic blood pressure78mm[Hg]S
1901-03-30Heart rate78/minS
1901-03-30Respiratory rate16/minS
1901-03-30Body temperature36.7CelS
1901-03-30Oxygen saturation in Arterial blood by Pulse oximetry98%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1901-03-30Hemoglobin [Mass/volume] in Blood12.6g/dL12-15.5 g/dLNormalS
1901-03-30MCV [Entitic mean volume] in Red Blood Cells by Automated count100fL80-100 fLNormalS
1901-03-30Platelets [#/volume] in Blood by Automated count19110*3/uL150-400 10*3/uLNormalS
1901-03-30Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma48U/L10-35 U/LHighS
1901-03-30Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma33U/L7-35 U/LNormalS
1901-03-30Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma132U/L5-40 U/LHighS
1901-03-30Albumin [Mass/volume] in Serum or Plasma3.6g/dL3.5-5 g/dLNormalS
1901-03-30Phosphatidylethanol [Mass/volume] in Blood24ng/mL<=20 ng/mLHighS
1901-03-30Liver stiffness by US.transient elastography9.6kPa<=8 kPaHighS
1901-03-30Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]9{score}S
1901-03-30Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]7{score}S

Physical Exam

Vital signs recorded on 1901-03-30; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 122/78, pulse 78; weight 50.9 kg, BMI 18.7
MouthExtraction socket healing cleanly
AbdomenSoft and non-tender; no ascites
SkinNo jaundice, spider angiomas or palmar erythema

Problems

ProblemClinical statusVerificationCodeProvenance
Alcohol use disorder, severe (nine of eleven DSM-5-TR criteria), daily drinking of about a pint of whiskey with heavier binges for many years; synthetic modern episode linked to her documented lifelong heavy drinkingactiveconfirmed F10.20S — Synthetic modern coding; DSM-5-TR severe alcohol use disorder maps to F10.20 when withdrawal is coded separately. Person-first language; not a claim about her real diagnosis.
Alcohol withdrawal, mild, at low risk of complications (PAWSS 3, CIWA-Ar 9 at intake; no past seizures or delirium tremens), managed as an outpatient with daily nurse checksresolvedconfirmed F10.230S — Synthetic withdrawal episode; resolved by the one-week visit.
Raised liver enzymes (AST 96, ALT 44, GGT 240 U/L) with a FIB-4 index of 3.93, above the cut point for possible advanced fibrosis; liver stiffness measurement plannedresolvedconfirmed R74.01S — Synthetic presenting finding; superseded when elastography and the clinical picture supported alcohol-associated steatotic liver disease.
Alcohol-associated steatotic liver disease, without cirrhosis: liver stiffness 9.6 kPa after four weeks without alcohol, falling enzymes, normal bilirubin, albumin, INR and plateletsactiveconfirmed K70.0S — Synthetic modern diagnosis made at the four-week visit.
Depressive symptoms during heavy drinking (PHQ-9 14, item 9 scored 0); whether they are alcohol-induced or an independent depression to be judged after two to four weeks without alcoholactiveprovisional F32.AS — Synthetic provisional finding; resolved as the PHQ-9 fell to 5 after ten weeks without alcohol, consistent with alcohol-induced depressive symptoms. Not a claim about her real mood.
Daily chewing tobacco for many years; not ready to stop at intakeactiveconfirmed F17.220S — Synthetic modern coding anchored to the documented chewing tobacco.
Underweight (BMI 18.4) with poor food intake, low folate, magnesium and phosphate, and slightly low albuminactiveconfirmed R63.6S — Synthetic finding anchored to a contemporary impression of poor nutrition (R).
Housing instability: staying in a spare room at a friend's house, with nowhere to go if that ends; has stayed in shelters in past wintersactiveconfirmed Z59.811S — Synthetic social need anchored to her documented poverty and moves from town to town.
Food insecurity: often goes without meals at the end of the monthactiveconfirmed Z59.41S — Synthetic social need anchored to her documented poverty.
Periapical abscess of a lower left molar with facial swelling and low-grade fever, on naltrexone; treated without opioids, tooth removed at the dental clinic the next day; resolvedresolvedconfirmed K04.7S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
Self-managementDrinking since the last visit (her own account, day by day), cravings and triggersEvery visitCompleted todayNo alcohol for four weeks; cravings milder
LaboratoryPEth, explained as part of care and not as a test of honestyAt baseline and about every one to two monthsCompleted today24 ng/mL, from 820
LaboratoryThiamine, folate and electrolytesThiamine before glucose and through recovery; electrolytes rechecked within a week if lowCompleted todayThiamine and folic acid daily; hemoglobin 12.6 g/dL, MCV 100 fL
Medication safetyMedicine for alcohol use disorder: adherence, side effects, opioid exposureEvery visitCompleted todayAbout eight of 21 oral doses missed; no side effects; changed to the monthly injection today
LaboratoryLiver enzymes on naltrexoneBaseline, within the first months of treatment, then periodicallyCompleted todayAST 48, ALT 33, GGT 132 U/L on naltrexone, all falling
ImagingLiver fibrosis: FIB-4, transient elastography, albumin, INR, plateletsElastography when FIB-4 is above 2.67, repeated after months without alcoholCompleted todayLiver stiffness 9.6 kPa; albumin 3.6 g/dL; platelets 191; FIB-4 1.92
ExaminationWeight, meals and food accessEvery visitCompleted todayWeight 50.9 kg, BMI 18.7; two meals a day on most days
SurveyDepression (PHQ-9) and anxiety (GAD-7) after two to four weeks without alcoholAt baseline, after two to four weeks without alcohol, then at least monthly while symptoms persistCompleted todayPHQ-9 9, item 9 scored 0; GAD-7 7
SurveySuicide-risk review, safety plan, firearm storage and the 988 Suicide & Crisis LifelineEvery visitCompleted todayNo thoughts of suicide or self-harm; rifle stored; 988 card carried
Self-managementPeer recovery support and mutual-help meetingsWeekly peer contact; meetings of her choiceCompleted todayTwo calls with the peer specialist; one women's meeting
Self-managementHousing, food, income and health coverageEvery visitCompleted todayMedicaid and SNAP approved; on the housing program waiting list
Self-managementChewing tobaccoEvery visitCompleted todayStill chewing; not ready to stop
Medication safetyNaloxoneReassess at every visitNot indicatedNo opioid use; she turned down pain pills offered to her

Goal progress:

Guideline basis: The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018); The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management (2020); The Healthcare Professional's Core Resource on Alcohol (2026); Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases (2019); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026)

Follow-up: Preventive visit in four weeks with the second naltrexone injection and vaccines. Ten-week review in six weeks. Weekly peer contact. Next scheduled visit 1901-04-27: periodic adult preventive visit. [S]